Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 6 for:    ttp488

Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease (STEADFAST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02080364
Recruitment Status : Terminated (Not due to safety but due to a lack of efficacy at the 5 mg azeliragon dose.)
First Posted : March 6, 2014
Last Update Posted : May 17, 2019
Sponsor:
Information provided by (Responsible Party):
vTv Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : June 1, 2018
  Actual Study Completion Date : June 1, 2018
  Certification/Extension First Submitted : May 8, 2019